NCT00467376View on ClinicalTrials.gov

Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

485

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2008

Conditions
Diabetes Mellitus
Interventions
DRUG

Insulin Glulisine

3 times a day before each meal

DRUG

Lispro

3 times a day before each meal

DRUG

Insulin Glargine

once daily

Trial Locations (1)

Unknown

Sanofi-Aventis, Beijing

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY